Metformin patient adherence
Pro Research Analysisby 
Searched over 200M research papers
Metformin Patient Adherence Rates and Measurement Methods
Adherence to metformin among patients with type 2 diabetes varies widely, with studies reporting adherence rates ranging from about 40% to over 90%, depending on the population and measurement methods used 1236+1 MORE. Direct measurement methods, such as blood sampling and pill counts, as well as indirect methods like self-reported questionnaires and pharmacy refill data, are commonly used to assess adherence 1258. For example, one study using both self-report and blood sampling found that 61.2% of patients were adherent, while another using prescription data reported that fewer than 50% of patients maintained optimal adherence 16. In contrast, a tertiary diabetes center reported adherence rates above 93% when using plasma metformin levels .
Factors Influencing Metformin Adherence
Patient-Related Factors
Several patient-related factors are linked to lower adherence, including lower education, passive lifestyle, low physical activity, smoking, and forgetfulness 23. Higher education status is consistently associated with better adherence 23. Depression and psychological barriers also negatively impact long-term adherence 15. Ethnic disparities exist, with some groups, such as Māori patients, showing lower adherence rates, which may be influenced by both patient preferences and health system factors .
Therapy-Related and System Factors
Complex dosing regimens, such as taking metformin more than twice daily, long-term therapy, and frequent changes in therapy, are associated with reduced adherence . The use of fixed-dose combination pills with other antidiabetic agents improves adherence, while switching to extended-release (XR) formulations does not consistently show a benefit 310. Cost and gastrointestinal side effects are common barriers, though metformin is generally inexpensive 410. The use of adherence aids, like pill boxes, can significantly improve adherence .
Impact of Adherence on Clinical Outcomes
Non-adherence to metformin is linked to poorer glycemic control, as indicated by higher HbA1c and blood glucose levels 28. Studies show that patients with higher adherence have significantly lower HbA1c levels and better overall glycemic outcomes . Long-term adherence to metformin is also associated with a reduced risk of developing type 2 diabetes in high-risk individuals and lower all-cause mortality 59. Additionally, adherence to metformin reduces the risk of cardiovascular events, including stroke and myocardial infarction, even when patients are on additional antiglycemic agents .
Strategies to Improve Metformin Adherence
Improving adherence requires addressing both patient and treatment barriers. Shared decision-making, patient education, and early identification of adherence problems are effective strategies 45. Using planned strategies, such as adherence aids and regular counseling, supports long-term adherence 15. Addressing side effects through formulation changes or alternative dosing may help, but evidence for the superiority of extended-release formulations is mixed 3410.
Conclusion
Metformin adherence among patients with type 2 diabetes is suboptimal and influenced by a range of patient, therapy, and system factors. Higher adherence is associated with better glycemic control, reduced risk of diabetes progression, lower cardiovascular risk, and improved survival. Multifaceted strategies, including patient education, use of adherence aids, and tailored support, are essential to optimize metformin adherence and improve patient outcomes 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic